MIAN
IONS icon

Mariner Independent Advisor Network’s Ionis Pharmaceuticals IONS Stock Holding History

Mariner Independent Advisor Network’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$563K Buy
12,729
+639
+5% +$26.9K 0.02% 451
2022
Q2 		$445K Sell
12,090
-9,394
-44% -$354K 0.02% 483
2022
Q1 		$813K Buy
+21,484
New +$703K 0.03% 390

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Mariner Independent Advisor Network's IONS Position: Q3 2022 in Review

Mariner Independent Advisor Network increased its Ionis Pharmaceuticals (IONS) stake by 5.3% in Q3 2022, buying an estimated $26.9K and bringing the position to 12,729 shares worth $563K. The position accounts for 0.02% of the portfolio, ranked #451.

Mariner Independent Advisor Network first reported a position in IONS in Q1 2022 and has held it in 3 quarters since. The position peaked at $813K in Q1 2022. 350 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • Mariner Independent Advisor Network held 12,729 shares of Ionis Pharmaceuticals worth $563K as of Q3 2022.
  • Mariner Independent Advisor Network bought 639 Ionis Pharmaceuticals shares in Q3 2022, an estimated $26.9K.
  • Ionis Pharmaceuticals made up 0.02% of Mariner Independent Advisor Network's portfolio in Q3 2022, its #451 holding.
  • Mariner Independent Advisor Network first reported a position in Ionis Pharmaceuticals in Q1 2022 and has held it in 3 quarters since.
  • Mariner Independent Advisor Network's Ionis Pharmaceuticals position peaked at $813K in Q1 2022.
  • 350 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on Mariner Independent Advisor Network's 13F filing for Q3 2022, filed 10 Nov 2022.